Loss of<i> SLC25A20</i> in Pancreatic Adenocarcinoma Reversed the Tumor-Promoting Effects of a High-Fat Diet
<b>Rationale:</b> Although it is known that High-fat diet (HFD) promotes the development of pancreatic ductal adenocarcinoma (PDAC), no direct link between HFD and cancer has been identified. Previously, we showed that ATP production by cancer cells depends on fatty acid oxidation (FAO); therefore, we hypothesized that blocking FAO may prevent HFD-induced promotion of PDAC growth. <b>Methods:</b> To determine whether FAO is increased in PDAC patients, we analyzed a tissue microarray by immunohistochemical staining to detect carnitine palmitoyl transferase I. To block FAO, <i>SLC25A20</i> (carnitine-acylcarnitine carrier) was knocked down in cancer cells, which was implanted for xenograft in mice and treated with a high-fat diet (HFD, 60% fat). To compare cancer development including survival rates, and histopathological differences were analyzed by crossbreeding of KPC mice (<i>Kras<sup>G12D/+;</sup> Trp53<sup>R172H/+;</sup> Pdx1-Cre</i>) with KPC/<i>Slc25a20<sup>+/-</sup></i> mice. <b>Results:</b> <i>SLC25A20</i> knockdown in cancer cells reduced ATP production and inhibited cell growth. Proteome analysis revealed that <i>SLC25A20</i> knockdown reduced cancer cell growth significantly due to inactivation of mTOR via decreased ATP production, ultimately leading to cell death. The median survival time of KPC/<i>Slc25a20<sup>+/-</sup></i> tumor-bearing mice was 3.1 weeks longer than that of KPC tumor-bearing mice. In mice fed an HFD, the growth of xenografts derived from <i>SLC25A20</i> knockdown PDAC cells was 65-95% lower than that of xenografts derived from control cells. <b>Conclusion:</b> Blocking FAO by <i>SLC25A20</i> knockdown reversed HFD-induced promotion of PDAC growth.
Authors
- Sung Hoon Sim (ORCID: https://orcid.org/0000-0002-1503-1075)
- Dawool Han (ORCID: https://orcid.org/0000-0003-2203-313X)
- Sang Myung Woo (ORCID: https://orcid.org/0000-0003-3786-4403)
- Woojin Ham
- Jeong Hwan Park (ORCID: https://orcid.org/0000-0001-9606-1630)
- Jong In Yook (ORCID: https://orcid.org/0000-0002-7318-6112)
- Nayoung Han (ORCID: https://orcid.org/0000-0003-4796-8564)
- Jung Won Chun (ORCID: https://orcid.org/0000-0003-1964-7501)
- Chaeyoung Kim (ORCID: https://orcid.org/0009-0005-0300-5004)
- Woosol Hong
- Kyung‐Hee Kim (ORCID: https://orcid.org/0000-0003-0214-0296)
- Ho Lee (ORCID: https://orcid.org/0000-0001-5573-742X)
- Joon Hee Kang
- Mingyu Kang (ORCID: https://orcid.org/0000-0002-5521-655X)
- Woo Jin Lee
- Wonyoung Choi
- Soo Youl Kim
Institutions
- Yonsei University (KR)
- National Cancer Center (US)
- National Cancer Center (KR)
- Yonsei University College of Dentistry
Publication Details
- Journal
- Theranostics
- Published
- 2025-05-25
- DOI
- https://doi.org/10.7150/thno.114912
- Citations
- 6
- Primary Topic
- Cancer, Lipids, and Metabolism
- Type
- article
- Field-Weighted Citation Impact
- 5.62